Skip to main content

Hyperlipoproteinemia of lipoprotein Lp(a)

  • Chapter
Atherosclerosis and Cardiovascular Disease
  • 71 Accesses

Abstract

Lp(a) is a lipoprotein with unknown physiological role. All we know for sure is that individuals with high Lp(a) levels are at an increased atherosclerosis risk. The Lp(a) plasma concentration correlates inversly with the molecular weight of the apo-a isoform; this is valid, however, only in healthy persons belonging to one ethnic group. Diseases, e.g. liver or kidney damage, pregnancy and menopause profundly alter plasma Lp(a) levels, and it also appears that fertile women have higher levels as compared to man.

Many studies of various laboratories demonstrate that plasma Lp(a) concentrations correlate with the incidence of atherosclerosis and myocardial infarction. In the healthy white western population, a treshold level of approx. 25 mg/dl seems to exist below which no increased atherosclerosis risk may be evident. This value certainely has to be adapted for different ethnic groups, as well as for individuals suffering from diseases known to influence Lp(a). Unfortunately we know today only little about the possible therapeutic manipulation of plasma Lp(a) concentrations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Berg, K. (1963) ‘A new serum type system in man - the Lp system’, Acta Pathol. Microbiol. Scand. 59, 369–382.

    Article  CAS  PubMed  Google Scholar 

  2. Kostner, G. M. (1976) ‘Lp(a) lipoproteins and the genetic polymorphisms in of lipoprotein B’, C. E. Day and R. S. Levy eds, Low Density Lipoproteins, Plenum Press,229–269.

    Google Scholar 

  3. Kostner, G. M., Krempler, F. and Sandhofer, F. (1981) ‘The lipoprotein Lp(a): Structure, metabolism and significance for vascular diseases’, Adv. Physol. Sci (Pergamon), 12, 527–534.

    Google Scholar 

  4. Kostner, G. M. (1988) ‘The affection of lipoprotein-a by lipid lowering drugs’, Recents Aspects of Diagnosis and Treatment of Lipoprotein Disorders, Alan R. Liss Inc., 255–263.

    Google Scholar 

  5. McLean J. W.,Tomlinson, J. E., Scanu, A. M. and Lawn, R. M. (1987) ‘DNA sequences of humen apolipoprotein-a is homologous to plasminogen’, Naturte 300, 132–137.

    Article  Google Scholar 

  6. Utermann, G., Menzel, H. J., Kraft H. G.,.Uba, H. C., Kremmler, H. G., and Seitz, (1987) ‘Lp(a) glycoprotein phenotypes’, J. Clin. Invest. 80, 458–465.

    Article  CAS  PubMed  Google Scholar 

  7. Dahlen, G., Erikson, C., Furberg, C. and Lundquist K. (1972) ‘Studies on an extra pre-ß lipoprotein fraction’,Acta Med. Scand. Suppl.,531, 1–35.

    CAS  PubMed  Google Scholar 

  8. Kostner, G. M., Avogaro, P., Cazzolato, G., Marth, E., and Bittolo Bob, G., (1981) ‘Lipoprotein lp(a) and the risk for myocardial infarction’, Atherosclerosis, 38, 51–61.

    Article  CAS  PubMed  Google Scholar 

  9. Höfler, G., Harnoncourt, F., Paschke, E., Mirt, W., Pfeiffer, K. P., and Kostner, G. M., (1988) ‘Lipoprotein Lp(a). A risk factor for myocardial infarctio’, Arteriosclerosis, 8, 398–401.

    Article  Google Scholar 

  10. Strobl, W., Widhalm, K., Kostner, G. M. and Pollak, A. (1983) ‘Serum apolipoproteins and Lp(a) in the first week of life’, Acta Paediatr. Scand., 72, 505–509.

    Article  CAS  PubMed  Google Scholar 

  11. Pagnan, A., Kostner, G. M., Braggion, M, and Ziron, L., (1982) ‘Relationship between sinking prelipoprotein (Lp(a)) and age in a family kindred’, Gerontology, 28, 381–385.

    Article  CAS  PubMed  Google Scholar 

  12. Zechner, R., Desoye, G., Schweditsch, M., Pfeiffer, K. H. and Kostner G. M., (1986) ‘Fluctuation of plasma lipoprotein lp(a) levels during pregnancy and post partum’, Metabolism, 35, 333–336.

    Article  CAS  PubMed  Google Scholar 

  13. Marth, E., Cazzolato, G., Bittolo Bon, G., Avogaro, P. and Kostner G. M., (1982) ‘Serum concentrations of Lp(a) and other lipoprotein parameters in heavy alcohol consumers’, Ann. Nutrit.Metabol., 26, 56–62.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Kluwer Academic Publishers

About this chapter

Cite this chapter

Kostner, G.M. (1990). Hyperlipoproteinemia of lipoprotein Lp(a). In: Descovich, G., Gaddi, A., Magri, G., Lenzi, S. (eds) Atherosclerosis and Cardiovascular Disease. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0731-7_17

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-0731-7_17

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6814-7

  • Online ISBN: 978-94-009-0731-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics